Bacterial lectins, cell-cell recognition and infectious disease.
about
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complexPorifera Lectins: Diversity, Physiological Roles and Biotechnological PotentialPlant as a plenteous reserve of lectinNMR solution structure of a cyanovirin homolog from wheat head blight fungusThe tyrosine gate of the bacterial lectin FimH: a conformational analysis by NMR spectroscopy and X-ray crystallographyModulating effects of the plug, helix, and N- and C-terminal domains on channel properties of the PapC usher.Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors.Competition triggers plasmid-mediated enhancement of substrate utilisation in Pseudomonas putidaThe pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae.An exclusive contract: specificity in the Vibrio fischeri-Euprymna scolopes partnership.Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipidsSynthesis and solvodynamic diameter measurements of closely related mannodendrimers for the study of multivalent carbohydrate-protein interactions.Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding proteinDifferential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture.Synthesis and biological evaluation of a library of glycoporphyrin compounds.Cytotoxicity of Pseudomonas aeruginosa internal lectin PA-I to respiratory epithelial cells in primary culture.Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells.Predominant effect of host genetics on levels of Lactobacillus johnsonii bacteria in the mouse gut.Adherence of Salmonella typhimurium to Caco-2 cells: identification of a glycoconjugate receptor.Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.Polyporus squamosus Lectin 1a (PSL1a) Exhibits Cytotoxicity in Mammalian Cells by Disruption of Focal Adhesions, Inhibition of Protein Synthesis and Induction of Apoptosis.Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence.Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae.Common themes in microbial pathogenicityAssessing Bacterial Interactions Using Carbohydrate-Based MicroarraysIdentification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicityInteraction of Bacteroides fragilis Toxin with Outer Membrane Vesicles Reveals New Mechanism of Its Secretion and Delivery.Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications.Microbial lectins and their prospective mitogenic potential.Anti-adhesion methods as novel therapeutics for bacterial infections.Binding sugars: from natural lectins to synthetic receptors and engineered neolectins.Multivalent glycoconjugate syntheses and applications using aromatic scaffolds.Leucocyte adhesion to cells. Molecular basis, physiological relevance, and abnormalities.Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA.Catch bond-mediated adhesion without a shear threshold: trimannose versus monomannose interactions with the FimH adhesin of Escherichia coli.Functional heterogeneity of type 1 fimbriae of Escherichia coli.Effect of Aminophenyl and Aminothiahexyl α-D-Glycosides of the Manno-, Gluco-, and Galacto-Series on Type 1 Fimbriae-Mediated Adhesion of Escherichia coli.Towards the development of antimicrobial drugs acting by inhibition of pathogen attachment to host cells: a need for polyvalency.Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosides.
P2860
Q24645503-E298E782-A00E-4EA5-A51C-3D293E5099D7Q26799322-F8CF2E90-C70C-4D99-8489-8F20CF0C03F4Q27027344-699FC9DF-9C4F-4A06-B14F-AB2874AA2043Q27667126-85FFC1A5-B817-47AC-8C4C-71FCD769855FQ27700666-0977604D-28BA-460D-879C-BCE9C4C13D28Q30157078-B085F3E0-16BC-4872-8F90-F11C0CF640F1Q30477190-4BE6B149-E739-4A66-8DB7-F7DBC5BC1AEAQ33474827-06FDD67D-349C-4FE2-AB2E-2AC7ED63C738Q33486161-04DFAD2F-6452-4CF3-9454-E312BA636004Q33601398-ACDBFF2A-98CF-460B-B3E9-72D268FC0A1CQ33641713-67767BA1-BE93-40D8-B45D-3B70A40B3D17Q34088664-DB8BCE6B-086E-46A8-9087-D3A143F39836Q34191664-35830010-C16A-4C53-AC33-6A9686837715Q34264778-EDB66512-8212-47B4-92E2-04193DD8E7F0Q34423462-84EBAEBD-DF32-4594-AD03-FE269079808DQ34541324-12821B59-E562-4321-BECF-C37FFC90234FQ34674254-A39AA964-2CAC-4E75-967B-EBDD7044BEE5Q35271907-664C531E-EE28-41D9-AC2E-26AEE11A2938Q35462245-17FF3FD5-7275-44D2-84D6-21D8793ABBACQ35647771-ED516655-0CBD-4FC7-9263-012FF8571382Q36257461-0CC600A6-BEAD-4DC2-B0CF-CC59A6E821DCQ36845297-F0B34B3F-D356-4301-B477-4CC42DC5C108Q36966722-A8E6B75C-F67D-4993-A609-15C9D6B1E379Q37055410-E34DA414-5E8D-49E4-B579-85A0F49F3415Q37200847-1BD8029F-6935-4DE4-A23D-1A7AD7706E18Q37410383-9B3F96B4-34B4-4635-BC12-18E97FECF4A7Q37588797-9D2D568F-1E4C-4BAB-83AB-DDC9321D60D8Q37712847-83E5692A-2AFD-4F89-A127-6FA69AA2FCB9Q38065207-623A0A7E-C0A1-4B3C-A7AB-D93EE1E33059Q38068610-42149E76-B3AF-4B41-8FD9-D3D531FE704AQ38077027-E67F7F30-F14E-45CA-8325-CF929FEC9E8CQ38080745-0BB77867-DAD5-4111-A2AE-4B433DBDA27CQ38205733-47CB92E6-4DB5-424F-A375-7206696A4A47Q38302979-5BA05ECF-CE45-41B1-8395-52CF20F5BF2AQ38314107-C29D1C84-CBAE-4976-9003-3FAF6DED4513Q38324920-2D640FEB-393D-4924-896D-D55802458470Q38369339-F8F2290A-5206-4E03-BDC9-2C1CA99FBAFDQ38672785-E0C55AE5-23EA-42C6-8BCB-3B2D7A339123Q39307431-5E47BFF9-142D-44F9-B589-89D7F19E9D36Q39340225-A90280A7-806A-41A9-9425-222534C8DC53
P2860
Bacterial lectins, cell-cell recognition and infectious disease.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Bacterial lectins, cell-cell recognition and infectious disease.
@en
Bacterial lectins, cell-cell recognition and infectious disease.
@nl
type
label
Bacterial lectins, cell-cell recognition and infectious disease.
@en
Bacterial lectins, cell-cell recognition and infectious disease.
@nl
prefLabel
Bacterial lectins, cell-cell recognition and infectious disease.
@en
Bacterial lectins, cell-cell recognition and infectious disease.
@nl
P2860
P1433
P1476
Bacterial lectins, cell-cell recognition and infectious disease.
@en
P2093
P2860
P304
P356
10.1016/0014-5793(87)80654-3
P407
P577
1987-06-01T00:00:00Z